These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 4152998
1. Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs. Turner-Warwick M. Proc R Soc Med; 1974 Jun; 67(6 Pt 2):541-7. PubMed ID: 4152998 [No Abstract] [Full Text] [Related]
2. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus]. Peltier AP. Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383 [No Abstract] [Full Text] [Related]
3. [The lung in connectivitis]. Schettini A, Iones F, D'Andrea A, Pucino A, Vatrella A, Marsico SA. Arch Monaldi; 1984 Apr; 39(1-2):3-26. PubMed ID: 6398036 [No Abstract] [Full Text] [Related]
4. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases]. Monegat JN, Joller-Jemelka HI, Grob PJ. Schweiz Med Wochenschr; 1974 Nov 09; 104(45):1614-23. PubMed ID: 4612703 [No Abstract] [Full Text] [Related]
5. Autoantibodies and the autoimmune diseases. Josephson AS. Bull N Y Acad Med; 1981 Sep 09; 57(7):631-7. PubMed ID: 6974027 [No Abstract] [Full Text] [Related]
6. [Autoantibodies in collagen diseases]. Meyer O. Ann Med Interne (Paris); 1986 Sep 09; 137(8):666-78. PubMed ID: 2436515 [No Abstract] [Full Text] [Related]
7. Studies on antinuclear antibodies. Seligmann M, Cannat A, Hamard M. Ann N Y Acad Sci; 1965 Jun 30; 124(2):816-32. PubMed ID: 4378822 [No Abstract] [Full Text] [Related]
8. [Pulmonary involvement in collagen diseases]. Siegenthaler W, Leutenegger H, Siegenethaler G, Medici T. Med Klin; 1975 Nov 07; 70(45):1801-14. PubMed ID: 593 [No Abstract] [Full Text] [Related]
9. The immunology of rheumatoid diseases. Koffler D. Clin Symp; 1979 Nov 07; 31(4):1-36. PubMed ID: 45382 [No Abstract] [Full Text] [Related]
11. [Degradation products of fibrinogen in connective tissue disorders: probable relation to the presence of microangiopathies]. Alarcon-Segovia D, Fishbein E, Zavala Mejía JL. Rev Invest Clin; 1971 Nov 07; 23(1):43-7. PubMed ID: 4397967 [No Abstract] [Full Text] [Related]
12. Comparative evaluation of antinuclear factor tests in rheumatic disorders. Willkens RF, Decker JL, Wilske KR. Med Clin North Am; 1968 May 07; 52(3):559-65. PubMed ID: 4385202 [No Abstract] [Full Text] [Related]
13. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases. Webb J, Whaley K, Lee P. Scott Med J; 1974 Jul 07; 19(4):171-5. PubMed ID: 4209789 [No Abstract] [Full Text] [Related]
16. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases]. Bambara LM, Biasi D, Caramaschi P, Codella O, Corrocher R, Serpelloni G, De Sandre G. Recenti Prog Med; 1985 Feb 07; 76(2):102-9. PubMed ID: 3887516 [No Abstract] [Full Text] [Related]
17. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases]. Riemekasten G, Hiepe F. Z Arztl Fortbild (Jena); 1992 Mar 10; 86(5):217-22. PubMed ID: 1585674 [No Abstract] [Full Text] [Related]